Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2
Open Access
- 21 May 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Pathogens
- Vol. 16 (5), e1008556
- https://doi.org/10.1371/journal.ppat.1008556
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformationScience, 2020
- Human B1 Cells are the Main Blood Group A-Specific B Cells That Have a Moderate Correlation With Anti-A Antibody TiterAnnals of Laboratory Medicine, 2020
- Absence of Neu5Gc and Presence of Anti-Neu5Gc Antibodies in Humans—An Evolutionary PerspectiveFrontiers in Immunology, 2019
- From “Serum Sickness” to “Xenosialitis”: Past, Present, and Future Significance of the Non-human Sialic Acid Neu5GcFrontiers in Immunology, 2019
- Development of α‐Gal–Antibody Conjugates to Increase Immune Response by Recruiting Natural AntibodiesAngewandte Chemie, 2019
- Evolution in primates by “Catastrophic‐selection” interplay between enveloped virus epidemics, mutated genes of enzymes synthesizing carbohydrate antigens, and natural anti‐carbohydrate antibodiesAmerican Journal of Physical Anthropology, 2018
- ABO Blood Group and Susceptibility to Severe Acute Respiratory SyndromeJAMA, 2005
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- Induction of Cytolytic Anti-Gal Antibodies in α-1,3-Galactosyltransferase Gene Knockout Mice by Oral Inoculation withEscherichia coliO86:B7 BacteriaInfection and Immunity, 2002
- Genetic regulation of the expression of ABH and Lewis antigens in tissues.1992